MedicationCoupons.org: FDA Approves Generic Metformin / Glucophage / Glumetza, for Type 2 Diabetes

MIAMI - Aug. 31, 2016 - PRLog -- In the beginning of August, Sun Pharmaceutical Industries revealed that one among its subsidiaries obtained USFDA's final acceptance for the abbreviated new drug application for producing a generic version of Glumetza's pills.

Sun Pharmaceutical  said that the drug is scheduled to be commercially launched in the United States within August.  The Glumetza pills are indicated for glycemic control in adults with iabetess mellitus type 2.  In the past year the Glumetza mwdication had annual earnings of approximately $1.2 billion, in the United States alone.

More specifixally, Glumetza, marketed under the tradename Glucophage and Metformin, amongst others, is the primary remedy for the aaleviation of type 2 diabetes. That is especially tru for individuals obese patients.  The medication is also used to combat polycystic ovary syndrome. Some studies even suggest  that Glumetza could even prevent the complications of cardiovascular disease and cancer in diabetics.  Two of its best benefits are that it can be taken orally and that its use does not contibute to obesity.

Solar Pharmaceutical Industries is fifth largest international designer generics manufacturer and India's leading pharmaceutical manufacturer.

*Get Metformin / Glucophage / Glumetza COUPONS at: http://MedicationCoupons.org ->